MICROPORT CARDIOFLOW MEDTECH CORPORATION MicroPort CardioFlow Medtech Corporation Share Price
Equities
2160
KYG6082P1054
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.03 HKD | +5.10% |
|
+11.96% | -36.42% |
| 04-16 | Microport Cardioflow Inks Services Deal with Subsidiary | MT |
| 04-15 | MicroPort CardioFlow Medtech Corporation Enters into the 2024 MP CardioAdvent Service Procurement Framework Agreement | CI |
| Sales 2023 | 336M 46.4M 363M 3.72B | Sales 2024 * | 449M 61.9M 485M 4.96B | Capitalization | 2.3B 317M 2.49B 25.42B |
|---|---|---|---|---|---|
| Net income 2023 | -472M -65.14M -510M -5.22B | Net income 2024 * | -169M -23.32M -183M -1.87B | EV / Sales 2023 | 10.6 x |
| Net cash position 2023 * | - 0 0 0 | Net cash position 2024 * | - 0 0 0 | EV / Sales 2024 * | 5.13 x |
| P/E ratio 2023 |
-7.36
x | P/E ratio 2024 * |
-13.4
x | Employees | 592 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 41.41% |
More Fundamentals
* Assessed data
More news
Latest transcript on MicroPort CardioFlow Medtech Corporation
More press releases
| 1 day | +5.10% | ||
| 1 week | +11.96% | ||
| Current month | -8.85% | ||
| 1 month | -1.90% | ||
| 3 months | -20.16% | ||
| 6 months | -35.22% | ||
| Current year | -36.42% |
1 week
0.92
1.03
1 month
0.851.16
Current year
0.851.63
1 year
0.852.49
3 years
0.8518.30
5 years
0.8522.20
10 years
0.8522.20
| Managers | Title | Age | Since |
|---|---|---|---|
| President | 58 | 31/12/21 | |
Guo Ming Chen
CHM | Chairman | 39 | 31/08/16 |
Liang Zhao
BRD | Director/Board Member | 45 | 31/12/05 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jonathan Chou
BRD | Director/Board Member | 60 | 14/01/21 |
Jun Jie Zhang
BRD | Director/Board Member | 47 | 04/08/19 |
Guo Ming Chen
CHM | Chairman | 39 | 31/08/16 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 1.03 | +5.10% | 6,238,001 |
| 25/04/24 | 0.98 | 0.00% | 3,902,000 |
| 24/04/24 | 0.98 | +1.03% | 2,676,005 |
| 23/04/24 | 0.97 | +4.30% | 4,846,117 |
| 22/04/24 | 0.93 | +1.09% | 3,569,016 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 09:08 am
More quotes
Microport Cardioflow Medtech Corp is a China-based investment holding company mainly engaged in the medical device industry. The Company is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The Company's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The Company mainly conducts business within the domestic market.
Calendar
26/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.9534
CNY
Average target price
2.412
CNY
Spread / Average Target
+153.01%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -36.42% | 317M | |
| +12.07% | 128B | |
| -9.04% | 10.65B | |
| +0.91% | 8.82B | |
| +16.72% | 7.19B | |
| +25.15% | 4.99B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B |
- Stock Market
- Equities
- 2160 Stock
